House Committee on Oversight and Reform Chairwoman Carolyn Maloney (Getty Images)
April 21, 2021 05:54 AM EDT
Pharma
FDA+
Manufacturing

House De­moc­rats call on Emer­gent ex­ecs to tes­ti­fy on qual­i­ty is­sues next month

Zachary Brennan

Senior Editor

The House Over­sight Com­mit­tee is in­ves­ti­gat­ing Covid-19 vac­cine pro­duc­er Emer­gent BioSo­lu­tions, which se­cured a $628 mil­lion US gov­ern­ment con­tract to make As­traZeneca and J …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times